Retinalamin

Retinalamin - drug used in ophthalmology to improve the functional state of the retina.

Structure and Composition

 Retinalamin
 The drug is released in the form of a lyophilisate for the preparation of a solution for intramuscular administration parabulbarly and in the form of a porous mass or a white powder. One vial contains complex polypeptide fractions of retinal pigs or cattle - 5 mg.

In bottles of 5 or 10 pieces.

Analogs Retinalamin

Retinalamin virtually no analogues. At the same indications can be used the following antioxidants (parabulbarnom) - Mildronat or Emoksipin. By analogues Retinalamin may also include drug Cortexin.

The pharmacological action of the drug

Peptide bioregulators, tissue regeneration stimulant. It stimulates the cellular elements of the retina and the photoreceptors contributes to improving the work of the outer segments of photoreceptors and RPE dystrophy. It restores the light sensitivity of the retina.

It promotes normalization of vascular permeability and stimulation of reparative processes for injuries and diseases of the retina.

Indications Retinalamin

According to the instructions Retinalamin indicated for the treatment:

  • peripheral and central tapetoretinalnoy abiotrophy;
  • diabetic retinopathy;
  • compensated primary open-angle glaucoma;
  • postinflammatory and posttraumatic central retinal dystrophy.

Contraindications

The drug is contraindicated in case of hypersensitivity to its components, as well as during pregnancy.

Dosing and dosing regimen Retinalamin

According to the instructions Retinalamin parabulbarly or intramuscularly administered 5-10 mg once daily. Duration of treatment - from five to ten days. If necessary, a repeated course of therapy after 3-6 months.  Retinalamin - powder for solution

Terms of a solution Retinalamin

The contents of the vial should be diluted in one or two ml of water for injection, Novocaine (procaine) 0, 5% NaCl solution or 0, 9%.

side effects

In the opinion of Retinalamin may cause allergic reactions.

Overdose

No reviews Retinalamin regarding overdose has been reported.

Conditions and terms

Retinalamin refers to List B drugs with a shelf life of no longer than 36 months.





Яндекс.Метрика